Photodynamic therapy: Shedding light on the biochemical pathways regulating porphyrin-mediated cell death

Histology and Histopathology

Volumn 16, Issue 1, 2001, Pages 309-317

  Granville, D J ^a   McManus, B M ^a   Hunt, D W C ^a  

^a QLT Inc   (United States)

Author keywords

Apoptosis; Bcl 2; Caspases; Mitochondria; Photodynamic therapy; Photosensitizer; Verteporfin; Visudyne

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; CALCIUM ION; CASPASE; HYPERICIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOTOFRIN; PHOTOSENSITIZING AGENT; PORPHYRIN DERIVATIVE; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; AUTOIMMUNE DISEASE; CALCIUM CELL LEVEL; CANCER; CARDIOVASCULAR DISEASE; CELL SURVIVAL; DRUG MECHANISM; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; IMMUNE RESPONSE; INTRACELLULAR MEMBRANE; LIGHT EXPOSURE; MITOCHONDRIAL MEMBRANE; NONHUMAN; PHOTODYNAMIC THERAPY; PROTEIN EXPRESSION; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; VIRUS INFECTION;

ANIMALS; APOPTOSIS; CELL DEATH; HUMANS; LIGHT; PHOTOCHEMOTHERAPY; PORPHYRINS;

EID: 0035132136     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (91)

1. The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane
2. The activation of the c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signaling pathways protects HeLa cells from apoptosis following photodynamic therapy with hypericin
3. The pathogenesis of psoriasis: Immunological facts and speculations
4. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: One-year results of 2 randomized clinical trials-TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group
5. Photodynamic therapy with verteporfin (Visudyne): Impact on ophthalmology and visual sciences
6. p53 suppresses the activation of the bcl-2 promoter by the brn-3a POU family transcription factor
7. Early release of mitochondrial cytochrome c and expression of mitochondrial epitope 7A6 with a porphyrin-derived photosensitizer: Bcl- 2 and Bcl-xL overexpression do not prevent early mitochondrial events but still depress caspase activity
8. The use of transcutaneous photodynamic therapy in the prevention of adjuvant-enhanced arthritis in MRL/lpr mice
9. Activation of SAPK/JNK by camptothecin sensitizes androgen-independent prostate cancer cells to Fas-induced apoptosis
10. Photodynamic therapy
11. Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model
12. Increased photosensitivity in HL60 cells expressing wild-type p53
13. Photodynamic therapy sensitivity is not altered in human tumor cells after abrogation of p53 function
14. Properties and applications of photodynamic therapy
15. Photodynamic therapy induces caspase-3 activation in HL-60 cells
16. Apoptosis: Molecular aspects of cell death and disease
17. Rapid cytochrome c release, activation of caspases 3, 6, 7 and 8 followed by Bap31 cleavage in HeLa cells treated with photodynamic therapy
18. Overexpression of Bcl-X(L) prevents caspase-3-mediated activation of DNA fragmentation factor (DFF) produced by treatment with the photochemotherapeutic agent BPD-MA
19. Photodynamic treatment with benzoporphyrin derivative monoacid ring A produces protein tyrosine phosphorylation events and DNA fragmentation in murine P815 cells
20. Bcl-2 overexpression blocks caspase activation and downstream apoptotic events instigated by photodynamic therapy
21. Release of cytochrome c, Bax migration, Bid cleavage, and activation of caspases 2, 3, 6, 7, 8, and 9 during endothelial cell apoptosis
22. Nuclear factor-kappaB activation by the photochemotherapeutic agent verteporfin
23. Mitochondria and apoptosis
24. The induction of partial resistance to photodynamic therapy by the protooncogene BCL-2
25. How does photodynamic therapy work?
26. Consequences of the photodynamic treatment of resting and activated peripheral T lymphocytes
27. Photodynamic therapy and immunity
28. Effects of BAPTA-AM and forskolin on apoptosis and cytochrome c release in photosensitized Chinese hamster V79 cells
29. Photodynamic therapy in dermatology
30. The NF-kappa B activation pathway: Its regulation and role in inflammation and cell survival
31. Regulation of fasligand expression during activation-induced cell death in T lymphocytes via nuclear factor kappaB
32. Photodynamic therapy: A mitochondrial inducer of apoptosis
33. The role of subcellular localization in initiation of apoptosis by photodynamic therapy
34. Photodynamic therapy induces expression of interleukin 6 by activation of AP-1 but not NF-kappa B DNA binding
35. Strong and prolonged induction of c-jun and c-fos proto-oncogenes by photodynamic therapy
36. Enhanced apoptotic response to photodynamic therapy after bcl-2 transfection
37. Activation of JNK and p38 but not ERK MAP kinases in human skin cells by 5-aminolevulinate-photodynamic therapy
38. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis
39. Mitochondrial control of apoptosis
40. Photodynamic therapy inhibition of experimental intimal hyperplasia: Acute and chronic effects
41. Photodynamic therapy inhibits experimental allograft rejection. A novel approach for the development of vascular bioprostheses
42. NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes
43. Transcutaneous photodynamic therapy alters the development of an adoptively transferred form of murine experimental autoimmune encephalomyelitis
44. Photodynamic therapy
45. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis
46. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors
47. Pyropheophorbide-a methyl ester-mediated photosensitization activates transcription factor NF-kappaB through the interleukin-1 receptor-dependent signaling pathway
48. Role of nuclear factor-kappa B in colon cancer cell apoptosis mediated by aminopyropheophorbide photosensitization
49. Photodynamic therapy: A review
50. Bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis
51. Isolation of the mitochondrial benzodiazepine receptor: Association with the voltage-dependent anion channel and the adenine nucleotide carrier
52. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
53. Identification of a p53-dependent negative response element in the bcl-2 gene
54. The biology of photodynamic therapy
55. Caspase structure, proteolytic substrates, and function during apoptotic cell death
56. Prolonged skin allograft survival after photodynamic therapy associated with modification of donor skin antigenicity
57. A 14;18 and a 8;14 chromosome translocation in a cell line derived from an acute B-cell leukemia
58. Amelioration of antigen-induced arthritis in rabbits by induction of apoptosis of inflammatory cells with local application of transdermal photodynamic therapy
59. Double identity for proteins of the Bcl-2 family
60. Bcl-2 family proteins
61. Dysregulation of apoptosis in cancer
62. BCL-2 family proteins: Regulations of cell death involved in the pathogenesis of cancer and resistance to therapy
63. 2+ influx in endoplasmic reticulum: A comparison with mitochondria
64. Nuclear factor kappa B binding activity in mouse L1210 cells following photofrin II-mediated photosensitization
65. Texaphyrins: New drugs with diverse clinical applications in radiation and photodynamic therapy
66. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome angioid streaks, and idiopathic causes
67. Inhibition of contact hypersensitivity with different analogs of benzoporphyrin derivative
68. Serial killers: Ordering caspase activation events in apoptosis
69. Cleavage of BID during cytotoxic drug and UV radiation-induced apoptosis occurs downstream of the point of Bcl-2 action and is catalysed by caspase-3: A potential feedback loop for amplification of apoptosis-associated mitochondrial cytochrome c release
70. Prevention of late lumen loss after coronary angioplasty by photodynamic therapy: Role of activated neutrophils
71. The peripheral-type benzodiazepine receptor: A protein of mitochondrial outer membranes utilizing porphyrins as endogenous ligands
72. Pyrrolic photosensitizers
73. Stimulation of stress-activated protein kinase and p38 HOG1 kinase in murine keratinocytes following photodynamic therapy with benzoporphyrin derivative
74. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway
75. Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11;14) chromosome translocation
76. Hypericin-induced photosensitization of HeLa cells leads to apoptosis or necrosis. Involvement of cytochrome c and procaspase-3 activation in the mechanism of apoptosis
77. Photodynamic therapy-induced apoptosis in lymphoma cells: Translocation of cytochrome c causes inhibition of respiration as well as caspase activation
78. Characterization of porphyrin interactions with peripheral type benzodiazepine receptors
79. Photodynamic tumor therapy: Mitochondrial benzodiazepine receptors as a therapeutic target
80. NF-kappaB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
81. Hypericin-induced apoptosis of human malignant glioma cells is light-dependent, independent of bcl-2 expression, and does not require wild-type p53
82. Localization and efficacy analysis of the phototherapeutic lutetium texaphyrin (PCI-0123) in the murine EMT6 sarcoma model
83. Rapid tyrosine phosphorylation of HS1 in the response of mouse lymphoma L5178Y-R cells to photodynamic treatment sensitized by the phthalocyanine Pc 4
84. Promotion of photodynamic therapy-induced apoptosis by stress kinases
85. Etk/Bmx, a PH-domain containing tyrosine kinase, protects prostate cancer cells from apoptosis induced by photodynamic therapy or thapsigargin
86. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked
87. Apoptosis during photodynamic therapy-induced ablation of RIF-1 tumors in C3H mice: Electron microscopic, histopathologic and biochemical evidence
88. A mitochondrial membrane protein defined by a novel monoclonal antibody is preferentially detected in apoptotic cells
89. Wild-type p53 protein potentiates phototoxicity of 2-BA-2-DMHA in HT29 cells expressing endogenous mutant p53
90. Caspase knockouts: Matters of life and death
91. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis